in the beta blocker heart attack trial , a double blind , randomized , controlled study , patients taking propranolol ( 180 or 240 mg/day ) initiated 5-21 days post myocardial infarction had 26 % fewer deaths than those taking placebo over a 25 month ( mean ) followup .
C0027051
heart attack
C0033497
propranolol